Overview
Solventum Corp
Latest 10-K: FY2025, filed Feb 27, 2026 · Open the 10-K (Inline XBRL) ↗
- Revenue
- $8.32B
- 0.9%YoYup from FY2024
- TotalRevenue
- Gross profit
- $4.45B
- 3.1%YoYdown from FY2024
- GrossProfit
- Operating income
- $2.18B
- 110.5%YoYup from FY2024
- OperatingIncome
- Net income
- $1.56B
- 224.8%YoYup from FY2024
- NetIncome
- Diluted EPS
- $8.88
- 221.7%YoYup from FY2024
- EPSDiluted
- Diluted shares
- 175.3M
- 0.9%YoYup from FY2024
- WeightedAvgSharesDiluted
At a glance
Growth
- Solventum Corp reported revenue of $8.32B for fiscal 2025, up 0.9% from fiscal 2024.
- Revenue grew faster than the median S&P 500 member in 0 of the last 3 fiscal years.
Profitability
- Operating margin was 26.2% and net margin was 18.7%, against a median net margin of 12.8% across S&P 500 members for the same fiscal year.
Per share
- Diluted EPS was $8.88, up 221.7% from the prior year.
Written from the filed figures on this page by fixed rules — no AI.
Data as of Oct 31, 2026 · Sources: SEC EDGAR 10-K
Financial statements
Annual figures from the 10-K, most recent fiscal year first.
Income Statement
4 annual periodsChip: YoY change.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | 3Y CAGR |
|---|---|---|---|---|---|
| Revenue | $8.32B0.9%up Benchmark median 6.4% | $8.25B0.7%up Benchmark median 4.5% | $8.20B0.8%up Benchmark median 4.8% | $8.13B Benchmark median 10.3% | 0.8% |
| Gross Profit Median of 315 / 498 | $4.45B3.1%down Benchmark median 6.8% | $4.59B2.1%down Benchmark median 5.5% | $4.69B0.0%unchanged Benchmark median 5.2% | $4.70B Benchmark median 8.3% | -1.8% |
| Operating Income Median of 373 / 498 | $2.18B110.5%up Benchmark median 7.3% | $1.04B38.8%down Benchmark median 7.4% | $1.69B0.1%down Benchmark median 4.9% | $1.69B Benchmark median 7.5% | 8.8% |
| Net Income | $1.56B224.8%up Benchmark median 4.8% | $0.48B64.4%down Benchmark median 5.7% | $1.35B0.2%up Benchmark median 1.9% | $1.34B Benchmark median 1.3% | 5.0% |
| EPS (Diluted) | $8.88221.7%up Benchmark median 6.2% | $2.7664.6%down Benchmark median 7.9% | $7.790.1%up Benchmark median 1.9% | $7.78 Benchmark median 1.5% | 4.5% |
Balance Sheet
4 annual periodsChip: YoY change.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | 3Y CAGR |
|---|---|---|---|---|---|
| Total Assets | $14.29B1.1%down Benchmark median 5.6% | $14.46B3.7%up Benchmark median 3.4% | $13.94B Benchmark median 4.1% | — | — |
| Total Liabilities Median of 357 / 498 | $9.24B19.6%down Benchmark median 6.4% | $11.50B405.0%up Benchmark median 1.9% | $2.28B Benchmark median 2.9% | — | — |
| Stockholders' Equity | $5.05B70.6%up Benchmark median 6.8% | $2.96B74.6%down Benchmark median 5.4% | $11.67B0.6%down Benchmark median 7.3% | $11.74B Benchmark median 2.5% | -24.5% |
| Cash & Equivalents | $878.00M15.2%up Benchmark median 5.2% | $762.00M292.8%up Benchmark median 1.9% | $194.00M Benchmark median 6.7% | — | — |
| Total Debt | $5.04B37.1%down Benchmark median 2.1% | $8.01Bn/m Benchmark median 0.2% | $0.00B Benchmark median 0.3% | — | — |
Cash Flow Statement
4 annual periodsChip: YoY change.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | 3Y CAGR |
|---|---|---|---|---|---|
| Operating Cash Flow | $0.37B68.9%down Benchmark median 6.3% | $1.19B38.1%down Benchmark median 4.8% | $1.92B14.1%up Benchmark median 9.9% | $1.68B Benchmark median -0.7% | -39.7% |
| Capital Expenditures | $379.00M0.3%down Benchmark median 5.4% | $380.00M31.0%up Benchmark median 2.8% | $290.00M15.5%up Benchmark median 11.3% | $251.00M Benchmark median 14.0% | 14.7% |
| Free Cash Flow Median of 378 / 498 | negative: -$0.01B101.2%down Benchmark median 7.3% | $0.81B50.5%down Benchmark median 6.1% | $1.63B13.8%up Benchmark median 8.8% | $1.43B Benchmark median -11.3% | n/m |
n/m: not meaningful — the base (the prior year, or the first year for the CAGR) was zero or negative, or a per-share figure’s share basis changed (stock split). “—” means the figure is not available.
Benchmark median = median of the companies in the benchmark universe on Dec 31 of each fiscal year, from their own 10-K filings; a change counts only companies whose prior year was positive. Each median uses every member that reports the line item; where fewer than 80% do (banks and insurers file no gross profit), the row names how many. Published where at least 250 companies report it. Updated 2026-10-27. This compares reported figures, not share-price returns. Methodology
Ratios & valuation
FY2025Every ratio read two ways: Wall Street’s popular formula and the value investor’s stricter one. Same question, same unit. Pick a ratio.
Valuation · Earnings yield
What a dollar of market value earned
11.2%
Wall Street
on net earnings
FY2024 4.2%
negative: −0.1%
Value investor
on free cash flow
FY2024 7.0%
Gap −11.3 pts: Value-investor figure 11.3 points lower
How it’s calculated
Wall Street · on net earnings
Diluted EPS ÷ fiscal-year-end share price (1 ÷ P/E)
pe_ratio (ratio table)
P/E 8.9×Value investor · on free cash flow
(Operating cash flow − capital expenditures) ÷ market capitalisation (fiscal-year-end close × weighted-average diluted shares)
free cash flow ÷ market cap
Valuation · Enterprise yield
What a dollar of enterprise value earned
14.8%
Wall Street
on EBITDA
FY2024 8.5%
12.1%
Value investor
on EBIT
FY2024 5.5%
Gap −2.7 pts: Value-investor figure 2.7 points lower
How it’s calculated
Wall Street · on EBITDA
EBITDA ÷ enterprise value (1 ÷ EV/EBITDA)
ev_ebitda (ratio table)
EV/EBITDA 6.8×Value investor · on EBIT
Operating income (EBIT) ÷ enterprise value: depreciation counts as a real cost
operating income ÷ (ev_ebitda × ebitda)
Valuation · Book yield
Net assets behind a dollar of market value
36.3%
Wall Street
on book equity
FY2024 25.8%
n/m
Value investor
on tangible book
FY2024 n/m
How it’s calculated
Wall Street · on book equity
Book value of equity ÷ market capitalisation (1 ÷ P/B)
pb_ratio (ratio table)
P/B 2.8×Value investor · on tangible book
Tangible book value (equity less goodwill and intangibles) ÷ market capitalisation
tangible_book_value_per_share ÷ (pb_ratio × book_value_per_share)
Quality · Return on capital
Profit earned on the money in the business
38.9%
Wall Street
ROE: net income ÷ equity
FY2024 6.6%
19.3%
Value investor
ROIC: after-tax operating profit ÷ invested capital
FY2024 7.3%
Gap −19.6 pts: Value-investor figure 19.6 points lower
How it’s calculated
Wall Street · ROE: net income ÷ equity
Net income ÷ average stockholders' equity (start and end of year), including noncontrolling interests. Buybacks shrink equity and lift it.
return_on_equity (ratio table)
Value investor · ROIC: after-tax operating profit ÷ invested capital
Operating profit after tax ÷ invested capital (total assets − cash − non-interest-bearing current liabilities), so leverage cannot flatter it
roic (ratio table)
Quality · Cash margin
Cash profit kept from each dollar of sales
32.1%
Wall Street
EBITDA margin
FY2024 19.3%
negative: −0.1%
Value investor
Free-cash-flow margin
FY2024 9.8%
Gap −32.2 pts: Value-investor figure 32.2 points lower
How it’s calculated
Wall Street · EBITDA margin
EBITDA ÷ revenue
ebitda ÷ revenue
Value investor · Free-cash-flow margin
(Operating cash flow − capital expenditures) ÷ revenue: taxes, interest, working capital and capex all paid
free cash flow ÷ revenue
Balance sheet · Liquidity
Short-term assets per dollar of bills due within a year
1.23×
Wall Street
Current ratio
FY2024 1.20×
0.89×
Value investor
Quick ratio, inventory excluded
FY2024 0.84×
Gap −0.34×: Value-investor figure 0.34 lower
How it’s calculated
Wall Street · Current ratio
Current assets ÷ current liabilities
current_ratio (ratio table)
Value investor · Quick ratio, inventory excluded
(Current assets − inventory) ÷ current liabilities
quick_ratio (ratio table)
Balance sheet · Debt cover
How many times one year of earnings repays all debt
0.53×
Wall Street
EBITDA ÷ total debt
FY2024 0.20×
0.00×
Value investor
FCF ÷ total debt
FY2024 0.10×
Gap −0.53×: Value-investor figure 0.53 lower
How it’s calculated
Wall Street · EBITDA ÷ total debt
EBITDA ÷ total debt (short-term + long-term)
ebitda ÷ total debt
Net debt/EBITDA 1.56×Value investor · FCF ÷ total debt
Free cash flow ÷ total debt: what is actually left to repay it
free cash flow ÷ total debt
Each ratio measures one thing two ways, in the same unit: the popular formula, then a stricter one, so a lower figure is the stricter reading. Gap = value-investor figure minus Wall Street figure, from the figures shown.
Price-based ratios use the fiscal-year-end closing price. Free cash flow = operating cash flow − capital expenditures (we compute it; filings rarely report it). n/m = not meaningful (denominator ≤ 0); “—” = not reported. Each ratio’s formulas are under “How it’s calculated”.
Smart money
Showing the most recent 4 annual periods. Get longer history on the Pro plan, or the full history (1993–present) plus the smart-money dataset and webhooks on Institutional.
Peers, filings & research
Research Reports
No published research on SOLV yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows on data pinned to its SEC filing. Be the first: run equity_research_brief on SOLV and publish the result to your public profile.
Cite this page
Data as of Oct 31, 2026. Canonical address: https://valuein.biz/data/SOLV
Valuein. (2026, October 31). Solventum Corp (SOLV) financial statements, earnings power and smart-money summary [Data set]. Source: SEC EDGAR filings. https://valuein.biz/data/SOLV
@misc{valuein_solv_2026,
author = {{Valuein}},
title = {Solventum Corp (SOLV) financial statements, earnings power and smart-money summary},
year = {2026},
howpublished = {\url{https://valuein.biz/data/SOLV}},
note = {Data as of 2026-10-31; source: SEC EDGAR filings}
}10-K filed Feb 27, 2026 · accession 0001964738-26-000007
Agents: every figure Valuein's tools return carries a fact_id that traces to its SEC filing.
point-in-time · survivorship-free · every number traceable to its SEC filing
Index names are trademarks of their owners; Valuein is not affiliated with or endorsed by any index provider.